Previous close | 210.05 |
Open | 210.05 |
Bid | 213.00 |
Ask | 220.40 |
Strike | 710.00 |
Expiry date | 2025-01-17 |
Day's range | 210.05 - 210.05 |
Contract range | N/A |
Volume | |
Open interest | 15 |
Praxis Precision Medicines, Inc. (PRAX) and Viking Therapeutics, Inc. (VKTX) gain from positive study updates.
Regeneron's (REGN) efforts to expand its oncology portfolio get a hit as the FDA refuses to approve the lymphoma drug odronextamab.
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...